The Race to the Finish Line: Medicalized Orgasms in Orgasm, Inc.
Friday, February 18th, 2011
Last week, just in time for the sexiest holiday of the year, the film Orgasm Inc. opened. Despite its racy title and advertising, though, the film’s message is a bit more sobering. It examines the commercial medicalization of female sexuality, specifically the race between pharmaceutical companies to find and patent a female form of Viagra, be it a topical cream, pill or hormonal patch. Filmmaker Liz Canner was originally hired to create explicit content for the drug company Vivus for their clinical trials, which lead her to her own documentation of how drug companies develop and talk about their drugs for improving female sexual functionality. Throughout the film, she illuminates how drug makers are neck in neck to get FDA approval to cure the disease known as “Female Sexual Dysfunction” (FSD), an ailment that some physicians and sexuality experts claim was fabricated by the drug companies themselves in order to open up a large potential market: namely, women experiencing concerns regarding their own sexual normalcy and sexual well being.






